22 September 2020
Please join us at a virtual industry roundtable on 24 September from 10-11am AEST, to launch the formation of Australia’s first Antimicrobial Resistance Network – the AAMRNet, and the release of a new report, ‘Fighting Superbugs: A Report on the Inaugural Meeting of Australia’s Antimicrobial Resistance Stakeholders’, prepared by MTPConnect in partnership with Biointelect.
MTPConnect’s Managing Director and CEO, Dr Dan Grant will officially launch the initiative, followed by a discussion with AAMRNet’s Steering Committee members facilitated by Jenny Herz, Biointelect Managing Director.
- Elizabeth de Somer, CEO, Medicines Australia
- Professor David Paterson, Director UQ Centre for Clinical Research, Faculty of Medicine at University of Queensland
- Paul Field, Australian Representative, Global Antibiotic Research and Development Partnership (GARDP) and Foundation for Innovative New Diagnostics (FIND)
- Julie Philips, Managing Director, Opal Biosciences and MTPConnect Director
Collaboration is the key to success and the AAMRNet aims to provide a unified voice to support and promote Australia’s role in the global fight against the growing threat of drug resistant infections.
The launch of the AAMRNet coincides with the birth date of Sir Howard Florey, the legendary Australian pharmacologist and pathologist who was born on 24 September in Adelaide in 1898. Florey shared the Nobel Prize in 1945 for his role in the development of penicillin that revolutionised medicine, saving millions of lives.
Let’s build on Florey’s legacy and make a major contribution in the global fight against antimicrobial resistance.
When: Thursday 24 September, 10:00am - 11:00am (AEST)
Where: Zoom webinar event
We hope you can join us. Register here.